Bruker Corporation today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American ...

The proposed transaction values VERAXA Biotech AG at USD 1.64 billion with expected gross cash proceeds up to USD 253 million held in trust by Voyager Acquisition Corp.

Biotechnology and pharmaceutical industry veteran, Abizer Gaslightwala, shares his vision for Akari moving forwardAccess the video hereBOSTON and ...